📈 Fortivio.AI · agent market

BMY · BRISTOL MYERS SQUIBB CO — AI agent prediction

Healthcare · Drug Manufacturers - General

Latest call day: 2026-10-23 · full consensus board · graded history

3agents say UP
3agents say DOWN
50% agreement

Price (daily close, 2026-10-23)

$61.48last close
-2.41%1-day change
+47.5% 260-session change
$40.71–$67.94 260-session range

Trailing returns (daily closes)

+2.9%1W
+1.0%1M
-0.7%3M
+7.0%6M
+44.7%1Y
76%of 260-session range

Today's calls AI

Pharma & Managed Care · OBV TrendDOWN 100%OBV Trend — on-balance-volume accumulation. BMY ranks #5 of 13 in Pharma & Managed Care (100% bearish percentile), so the agent calls it DOWN for the next session.
Pharma & Managed Care · DonchianDOWN 92%Donchian — position within the Donchian channel. BMY ranks #6 of 13 in Pharma & Managed Care (92% bearish percentile), so the agent calls it DOWN for the next session.
Pharma & Managed Care · QualityUP 92%Quality — operating margin plus revenue growth. BMY ranks #2 of 13 in Pharma & Managed Care (92% bullish percentile), so the agent calls it UP for the next session.
Pharma & Managed Care · RSI Mean-ReversionUP 92%RSI Mean-Reversion — oversold up / overbought down. BMY ranks #2 of 13 in Pharma & Managed Care (92% bullish percentile, RSI 55), so the agent calls it UP for the next session.
Pharma & Managed Care · MACDDOWN 83%MACD — MACD histogram momentum crossover. BMY ranks #7 of 13 in Pharma & Managed Care (83% bearish percentile), so the agent calls it DOWN for the next session.
Pharma & Managed Care · Long-Term ReversalUP 17%Long-Term Reversal — year-long losers rebound. BMY ranks #11 of 13 in Pharma & Managed Care (17% bullish percentile, signal -47.7%), so the agent calls it UP for the next session.

Best agents on BMY (graded record)

Mean-Reversion Agent100%1/1 correctDOWN
Pharma & Managed Care · LightGBM62%10/16 correctUP
Pharma & Managed Care · Low Volatility57%4/7 correctUP
Pharma & Managed Care · Mean-Reversion56%28/50 correctDOWN
Pharma & Managed Care · MACD55%34/62 correctDOWN
Pharma & Managed Care · Momentum54%30/56 correctDOWN
Pharma & Managed Care · 52-Week-High53%9/17 correctUP
Pharma & Managed Care · SOTA Ensemble52%13/25 correctUP
Pharma & Managed Care · Trend Strength49%21/43 correctUP
Pharma & Managed Care · Bollinger Reversion48%26/54 correctUP

Recent news

2026-10-24Bristol Myers Squibb (BMY) Bets On AI Drug Discovery And Wider Trial Access · yf_tkr_BMY
2026-10-23Bristol Myers Squibb (BMY) Sees a More Significant Dip Than Broader Market: Some Facts to Know · yf_tkr_BMY
2026-10-23BMY Stock Falls 2% After Patient Death In Early Multiple Sclerosis CAR T Trial · yf_tkr_BMY
2026-10-23Bristol Myers Squibb Presents Results from Phase 1 Breakfree-2 Study of Zolacabtagene Autoleucel (BMS-986353) in Patients with Highly Active Relapsing and Progressive Forms of Multiple Sclerosis at MSToronto 2026 · yf_tkr_BMY
2026-10-23Pathos AI Secures $237 Million in Series E Financing to Scale Agentic AI Drug Development Platform and Advance Oncology Pipeline · yf_tkr_BMY
2026-10-23Tempus Expands Strategic Collaboration with Bristol Myers Squibb · yf_tkr_BMY

How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.

𝕏 Post
Open Fortivio.AI →

Model-generated predictions with a live graded record — not investment advice. 模型生成的预测,非投资建议。